Contextualizing & Responding to HIV Risk Behaviors

Completed · Not applicable

Conditions studied: Human Immunodeficiency Virus

In brief

The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of a an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART) adherence and risk reduction intervention, Project ADHerence Education and Risk Evaluation (ADHERE). Project ADHERE was compared to a single-session group-based medication adherence intervention, Medication Adherence and Care Engagement (MACE). A secondary aim was to examine the impact of Project ADHERE on HIV risk behaviors (i.e., illicit drug use and unprotected sexual behavior). This study was designed to inform, design, and pilot test the two antiretroviral medication adherence interventions for HIV-infected formerly incarcerated individuals.

Key facts

Study ID

NCT03300908

Run by

Columbia University

People needed

32

Starts

2016-07-05

Expected to finish

2016-12-21

Last updated by the study team

2017-10-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years of age
• HIV seropositive with "detectable" viral load (VL)(defined as >50 copies/mL)
• history of drug use (used illicit drugs within the past year)
• experienced incarceration in prison or jail within the past five years

You may not qualify if…

• living in a healthcare or assisted living facility
• experienced incarceration longer than five years ago

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.